Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
MedTech
Newly minted MiniMed nets CE mark for 780G pump, Instinct CGM
On its public debut, Medtronic’s former diabetes division MiniMed has scored European approval to connect its insulin pump with Abbott's bespoke CGM.
Conor Hale
Mar 11, 2026 10:05am
Salspera plans $91M IPO to fund salmonella-based cancer therapy
Mar 11, 2026 6:45am
Behind Generate's 'feverish' race to raise $400M IPO
Feb 27, 2026 3:36am
Medtronic's diabetes business MiniMed eyes $784M IPO
Feb 24, 2026 9:35am
Generate plans $425M IPO to bankroll phase 3 asthma trials
Feb 23, 2026 9:42am
Preclinical eye disease biotech sets sights on $17M NYSE IPO
Feb 18, 2026 8:55am
